# US 2026/0096975 A1 · Active ingredient combinations of alkylamidothiazoles and one or more biopolymers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0096975 A1
- Document ID: US20260096975A1
- Status: Published application
- Kind: A1
- Application number: 19/108,523
- Filed: 2023-09-05
- Published: 2026-04-09
- Earliest claimed: 2022-09-21
- Assignees: Beiersdorf AG
- Applicants: Beiersdorf AG
- Inventors: Melina MEYER; Caroline PLEHN; Uta MEIRING; Aylin STUHR; Sylke HANSSON
- Web page: https://patentgrep.com/patent/US20260096975A1

## CPC

- A61K 8/49: containing heterocyclic compounds
- A61K 8/73: Polysaccharides
- A61K 8/732: {Starch; Amylose; Amylopectin; Derivatives thereof}
- A61Q 19/02: for chemically bleaching or whitening the skin
- A61K 2800/5922: At least two compounds being classified in the same subclass of A61K8/18
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Active ingredient combinations of one or more alkylamidothiazoles and one or more cosmetically or dermatologically acceptable biopolymers suitable for increasing the viscosity of an aqueous solution, selected from the group of the polysaccharides esterified and/or etherified with the alcohols provided with one or more hydroxyl groups and/or carboxylic acids and the unesterified and unetherified polysaccharides that are composed of interlinked glucose and/or mannose and/or galactose and/or glucuronic acid and/or rhamnose units, wherein, if xanthan or hydroxypropyl starch phosphate is selected as biopolymer, at least one further biopolymer must be present.

## Claims

### Claim at position 1

-12. (canceled)

### Claim 13

An active ingredient combination, wherein the combination comprises (i) one or more alkylamidothiazoles and (ii) one or more cosmetically or dermatologically acceptable biopolymers which are capable for increasing a viscosity of an aqueous solution and are selected from polysaccharides etherified and/or esterified with alcohols having one or more hydroxyl groups and/or with carboxylic acids as well as unetherified and unesterified polysaccharides, the polysaccharides being composed of interlinked glucose and/or mannose and/or galactose and/or glucuronic acid and/or rhamnose units, provided that if xanthan or hydroxypropyl starch phosphate is selected as biopolymer, at least one further biopolymer is present.

### Claim 14 (depends on 13)

The active ingredient combination of claim 13, wherein (ii) comprises one or more of dehydroxanthan, gellan gum, xanthan, hydroxypropyl starch phosphate.

### Claim 15 (depends on 14)

The active ingredient combination of claim 14, wherein (ii) comprises (a) dehydroxanthan, (b) gellan, (c) xanthan, and (d) hydroxypropyl starch phosphate, weight ratios of (a):(b), (a):(c), (a):(d), (b):(c), (b):(d) and (c):(d) being independently rational numbers of from 0 to 10.

### Claim 16 (depends on 14)

The active ingredient combination of claim 14, wherein (ii) comprises (a) dehydroxanthan, (b) gellan, (c) xanthan, and (d) hydroxypropyl starch phosphate, weight ratios (a):(b):(c):(d) in relation to another being (0.1 to 5):(0.1 to 5):(0.1 to 5):(0.1 to 5).

### Claim 17 (depends on 13)

The active ingredient combination of claim 13, wherein (i) comprises one or more alkylamidothiazoles of formula
in which
R1, R2, X and Y are different, partially identical or entirely identical and independently have the following meanings:
R1=—C1-C24 alkyl (linear and branched), —C1-C24 alkenyl (linear and branched), —C1-C8 cycloalkyl, —C1-C8 cycloalkyl-alkylhydroxy, —C1-C24 alkylhydroxy (linear and branched), —C1-C24 alkylamine (linear and branched), —C1-C24 alkylaryl (linear and branched), —C1-C24 alkylaryl-alkyl-hydroxy (linear and branched), —C1-C24 alkylheteroaryl (linear and branched), —C1-C24 alkyl-O—C1-C24 alkyl (linear and branched), —C1-C24 alkyl-morpholino, —C1-C24 alkyl-piperidino, —C1-C24 alkyl-piperazino, —C1-C24 alkyl-piperazino-N-alkyl,
R2=H, —C1-C24 alkyl (linear and branched), —C1-C24 alkenyl (linear and branched), —C1-C8 cycloalkyl, —C1-C24 hydroxyalkyl (linear and branched), —C1-C24 alkylaryl (linear and branched), —C1-C24 alkylheteroaryl (linear and branched),
X=—H, —C1-C24 alkyl (linear and branched), —C1-C24 alkenyl (linear and branched), —C1-C8 cycloalkyl, —C1-C24 aryl (optionally mono- or polysubstituted by —OH, —F, —Cl, —Br, —I, —OMe, —NH2, —CN), —C1-C24 heteroaryl (optionally mono- or polysubstituted by —OH, —F, —Cl, —Br, —I, —OMe, —NH2, —CN), —C1-C24 alkylaryl (linear and branched), —C1-C24 alkylheteroaryl (linear and branched), -aryl (optionally mono- or polysubstituted by —OH, —F, —Cl, —Br, —I, —OMe, —NH2, —CN), -phenyl, -2,4-dihydroxyphenyl, -2,3-dihydroxyphenyl, -2,4-dimethoxyphenyl, -2,3-dimethoxyphenyl,
Y=H, —C1-C24 alkyl (linear and branched), —C1-C24 alkenyl (linear and branched), —C1-C8 cycloalkyl, —C1-C24 aryl, —C1-C24 heteroaryl, —C1-C24 alkylaryl (linear and branched), —C1-C24 alkylheteroaryl (linear and branched), -aryl, -phenyl, -2,4-dihydroxyphenyl, -2,3-dihydroxyphenyl, -2,4-dimethoxyphenyl, -2,3-dimethoxyphenyl, —COO-alkyl, —COO-alkenyl, —COO-cycloalkyl, —COO-aryl, —COO-heteroaryl,
and X, Y may optionally also=fused aromatic,
where X and Y may form, with one another, aromatic or aliphatic homo- or heterocyclic ring systems having up to n ring-forming atoms, and where the number n may assume values from 5 to 8, and the respective ring systems in turn may be substituted by up to n−1 alkyl groups, hydroxyl groups, carboxyl groups, amino groups, nitrile functions, sulfur-containing substituents, ester groups and/or ether groups,
the alkylamidothiazole(s) being present as either free base or as cosmetically and dermatologically usable salts.

### Claim 18 (depends on 13)

The active ingredient combination of claim 13, wherein (i) comprises one or more alkylamidothiazoles of the following formulae:
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)pivalamide
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)isobutyramide
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)butyramide
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)heptanamide
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)-6-hydroxyhexanamide
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)-3-hydroxypropanamide
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)-2-methoxyacetamide
3-amino-N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)propanamide
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)acetamide
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)-4-(hydroxymethyl)cyclohexanecarboxamide
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)cyclohexanecarboxamide
and
N-(4-(2,4-dihydroxyphenyl)thiazol-2-yl)-2-(4-(hydroxymethyl)phenyl)acetamide

### Claim 19 (depends on 13)

The active ingredient combination of claim 13, wherein the one or more alkylamidothiazoles are present as one or more of a halide, carbonate, ascorbate, sulfate, acetate and/or phosphate.

### Claim 20 (depends on 13)

A cosmetic or dermatological preparation, wherein the preparation comprises the active ingredient combination of claim 13.

### Claim 21 (depends on 20)

The preparation of claim 20, wherein the preparation comprises from 0.000001% to 10% by weight of (i), based on a total weight of the preparation.

### Claim 22 (depends on 20)

The preparation of claim 20, wherein the preparation comprises from 0.0001% to 3% by weight of (i), based on a total weight of the preparation.

### Claim 23 (depends on 20)

The preparation of claim 20, wherein the preparation comprises from 0.001% to 1% by weight of (i), based on a total weight of the preparation.

### Claim 24 (depends on 20)

The preparation of claim 20, wherein the preparation comprises from 0.0001% to 10% by weight of (ii), based on a total weight of the preparation.

### Claim 25 (depends on 20)

The preparation of claim 20, wherein the preparation comprises from 0.001% to 5% by weight of (ii), based on a total weight of the preparation.

### Claim 26 (depends on 20)

The preparation of claim 20, wherein the preparation comprises from 0.005% to 3% by weight of (ii), based on a total weight of the preparation.

### Claim 27 (depends on 20)

The preparation of claim 20, wherein the preparation has a pH of from 7 to 9.

### Claim 28 (depends on 20)

The preparation of claim 20, wherein the preparation has a pH of from 7 to 8.

### Claim 29 (depends on 20)

The preparation of claim 20, wherein the preparation has a pH of from 7.4 to 7.6.

### Claim 30 (depends on 20)

A method for lightening human skin, wherein the method comprises applying to skin the preparation of claim 20 in an amount which is effective for lightening skin.
